Mortality Trends and Disparities in Cardiovascular Disease and Amyloidosis: A Retrospective Population Study in the United States (1999–2020) - Takeaways - MDSpire

Mortality Trends and Disparities in Cardiovascular Disease and Amyloidosis: A Retrospective Population Study in the United States (1999–2020)

  • By

  • Faizan Ahmed

  • Tehmasp Rehman Mirza

  • Zoha Iftikhar

  • Haris Bin Tahir

  • Fenilkumar Kotadiya

  • Anika Goel

  • Haider Hussain Shah

  • Saman Rauf

  • Yusra Junaid

  • Talha Qadeer

  • Abdul Waheed

  • Najam Gohar

  • January 30, 2026

  • 0 min

Share

  • 1

    Amyloidosis is increasingly recognized as a significant contributor to cardiovascular morbidity, especially in older adults with heart failure.

  • 2

    Recent advancements in diagnostics have led to a rise in amyloidosis detection, yet it remains underdiagnosed due to nonspecific symptoms.

  • 3

    The study analyzed U.S. mortality data from 1999 to 2020, revealing an upward trend in age-adjusted mortality rates for amyloidosis and cardiovascular disease.

  • 4

    Black patients experience higher rates of hereditary ATTR amyloidosis and face significant disparities in health outcomes and access to care.

  • 5

    The research highlights the intersectional mortality burden of amyloidosis and cardiovascular disease, emphasizing the need for targeted management.

Original Source(s)

Related Content